Results 51 to 60 of about 2,714 (211)

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola   +5 more
wiley   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm   +2 more
wiley   +1 more source

Visibility Is Also a Form of Scientific Inequality

open access: yesThe Bulletin of the Ecological Society of America, EarlyView.
Abstract Recognition in science signals authority and helps determine which knowledge informs research agendas, funding decisions, and career trajectories. However, media coverage of awards often amplifies senior male scientists while marginalizing early‐career and female researchers, even when they receive the same distinctions.
Luisa Maria Diele‐Viegas
wiley   +1 more source

MaaS and GDPR: an overview

open access: yesCoRR, 2017
In MaaS (Mobility as a Service), means of transport are virtualized in mobility resources and provided to users using the Internet. From a legal perspective, this model of ITS (Intelligent Transport System) raises several concerns with regard to data protection.
openaire   +2 more sources

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

open access: yesBMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng   +4 more
wiley   +1 more source

Orchard netting impacts on biodiversity leading to cascading effects at the ecosystem level

open access: yesBiological Reviews, EarlyView.
ABSTRACT Agriculture must ensure food production without further compromising the ecosystem functions upon which it depends. Agricultural practices should therefore avoid harming farmland biodiversity, especially of taxa that supply the key ecosystem services (e.g.
Corrado Alessandrini   +13 more
wiley   +1 more source

Development path of MaaS platforms in China

open access: yesJournal of Highway and Transportation Research and Development
As urbanization progresses, a novel urban transportation paradigm known as Mobility as a Service (MaaS) has emerged, addressing the principles of environmentally friendly travel and sustainable transport development.
Wenkai Zhan   +4 more
doaj   +1 more source

Quality Assessment Method for Mobility as a Service

open access: yesPromet (Zagreb), 2020
The ongoing development of the concept ‘Mobility as a Service (MaaS)’ along with Shared Mobility contributes to the integration of transportation systems. Several MaaS or similar services are already in operation.
Yinying He, Csaba Csiszár
doaj   +1 more source

Revertant Mosaicism Obscures Long‐Awaited Molecular Confirmation of Diamond‐Blackfan Anemia

open access: yes
American Journal of Medical Genetics Part A, EarlyView.
Nicholas A. Borja, Mustafa Tekin
wiley   +1 more source

Home - About - Disclaimer - Privacy